HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Osher, E. Articles by Stern, N. Search for Related Content PubMed PubMed Citation Articles by Osher, E. Articles by Stern, N. Social Bookmarking                What's this?

Diastolic Pressure in Type 2 Diabetes

Can target systolic pressure be reached without "diastolic hypotension"?

¹ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
² Institute of Endocrinology, Metabolism, and Hypertension, Tel Aviv-Sourasky Medical Center, Tel Aviv, Israel

Address correspondence and reprint requests to Naftali Stern, MD, Institute of Endocrinology, Metabolism,Hypertension, Tel Aviv-Sourasky Medical Center, 6 Weizmann St., Tel Aviv 64239, Israel. E-mail: stern{at}tasmc.health.gov.il

The practicality of vigorous lowering of systolic pressure in diabetes to <130 mmHg remains uncertain. Baseline blood pressure data from several recent trials indicate that, in diabetic subjects, there is nearly a fourfold excess in systolic pressure (the difference between baseline pressure and target pressure) over diastolic pressure with respect to the recommended systolic/diastolic target pressure of <130/80 mmHg. Additionally, systolic pressure was 2–3 mmHg higher and diastolic pressure was 1–3 mmHg lower in diabetic hypertensive than in nondiabetic hypertensive individuals, which adds 4 mmHg to pulse pressure and also to the difference between the excess systolic and excess diastolic pressure. We attempted to force (titrate both systolic and excess diastolic pressure) systolic and diastolic blood pressure to <130/85 mmHg based on Joint National Committee VI guidelines in the setting of a clinical practice in 257 diabetic patients. Although target systolic pressure was attained in a third of this cohort, in 57% of the patients, the attained diastolic pressure was 70 mmHg. Patients with final diastolic pressure <70 mmHg were older, had a higher prevalence of coronary artery disease, and had higher initial systolic and pulse pressures. Review of achieved blood pressure in studies such as the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) indicates that a significant fraction of the diabetic subjects’ diastolic pressure was also driven down to <70 mmHg or even <60 mmHg. Thus, attempted lowering of blood pressure to target systolic pressure is associated with inordinate lowering of diastolic pressure in a significant number of patients. Whether the benefits of tight systolic control to <130 mmHg outweigh the risks of excessive diastolic reduction, especially in older diabetic subjects or diabetic patients with coronary artery disease, remains unresolved.

Abbreviations: ALLHAT, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial • ASCOT-BPLA, Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm • INVEST, International Verapamil-Trandolapril Study

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?